{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:23:00Z","timestamp":1790752980733,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.beem.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T10:52:19Z","timestamp":1517482339000},"page":"165-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Aberrant G-protein coupled hormone receptor in adrenal diseases"],"prefix":"10.1016","volume":"32","author":[{"given":"Matthieu","family":"St-Jean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada El","family":"Ghorayeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bourdeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9996","key":"10.1016\/j.beem.2018.01.003_bib1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.beem.2018.01.003_bib2","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2018.01.003_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mce.2011.10.006","article-title":"The cAMP pathway and the control of adrenocortical development and growth","volume":"351","author":"de Joussineau","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2018.01.003_bib4","series-title":"Adrenal disorders: physiology, pathophysiology and treatment","article-title":"Pathophysiology and genetic landscape of adrenocortical tumors and hyperplasias","author":"El Ghorayeb","year":"2017"},{"issue":"6","key":"10.1016\/j.beem.2018.01.003_bib5","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/joim.12452","article-title":"Genetics of adrenocortical tumours","volume":"280","author":"\u00c5kerstr\u00f6m","year":"2016","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.beem.2018.01.003_bib6","doi-asserted-by":"crossref","first-page":"M121","DOI":"10.1530\/EJE-15-0532","article-title":"Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?","volume":"173","author":"Drougat","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.01.003_bib7","first-page":"75","article-title":"Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome","volume":"22","author":"Lacroix","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2018.01.003_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2009.03689.x","article-title":"Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction","volume":"73","author":"Lacroix","year":"2010","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2018.01.003_bib9","doi-asserted-by":"crossref","first-page":"M45","DOI":"10.1530\/EJE-15-0200","article-title":"Multiple aberrant hormone receptors in Cushing's syndrome","volume":"173","author":"El Ghorayeb","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2018.01.003_bib10","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"72","key":"10.1016\/j.beem.2018.01.003_bib11","first-page":"27","article-title":"Role of ACTH and other hormones in the regulation of aldosterone production in primary aldosteronism","volume":"7","author":"El Ghorayeb","year":"2016","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2018.01.003_bib12","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1530\/JOE-14-0597","article-title":"An update on novel mechanisms of primary aldosteronism","volume":"224","author":"Zennaro","year":"2015","journal-title":"J\u00a0Endocrinol"},{"issue":"33","key":"10.1016\/j.beem.2018.01.003_bib13","doi-asserted-by":"crossref","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","article-title":"Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands","volume":"112","author":"Nishimoto","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.beem.2018.01.003_bib14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/EJE-08-0711","article-title":"Screening for membrane hormone receptor expression in primary aldosteronism","volume":"160","author":"Zwermann","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2018.01.003_bib15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1055\/s-0029-1243602","article-title":"Aberrant hormone receptors in primary aldosteronism","volume":"42","author":"Mazzuco","year":"2010","journal-title":"Horm Metab Res"},{"issue":"5","key":"10.1016\/j.beem.2018.01.003_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/EJE-13-0308","article-title":"Autocrine\/paracrine regulatory mechanisms in adrenocortical neoplasms responsible for primary adrenal hypercorticism","volume":"169","author":"Lefebvre","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.01.003_bib17","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1016\/S0021-9258(18)61876-9","article-title":"Multiple specific hormone receptors in the adenylate cyclase of an adrenocortical carcinoma","volume":"246","author":"Schorr","year":"1971","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.beem.2018.01.003_bib18","first-page":"530","article-title":"Cushing syndrome with food-dependent periodic hormonogenesis","volume":"10","author":"Hamet","year":"1987","journal-title":"Clin Invest Med"},{"issue":"14","key":"10.1016\/j.beem.2018.01.003_bib19","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM199210013271402","article-title":"Gastric inhibitory polypeptide-dependent cortisol hypersecretion\u2013a new cause of Cushing's syndrome","volume":"327","author":"Lacroix","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.beem.2018.01.003_bib20","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM199210013271403","article-title":"Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide","volume":"327","author":"Reznik","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.beem.2018.01.003_bib21","first-page":"3168","article-title":"Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells","volume":"81","author":"De Herder","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"18","key":"10.1016\/j.beem.2018.01.003_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92184","article-title":"Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome","volume":"2","author":"Lecoq","year":"2017","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.beem.2018.01.003_bib23","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1210\/jc.83.8.2781","article-title":"Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome","volume":"83","author":"N'Diaye","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.beem.2018.01.003_bib24","first-page":"3134","article-title":"Cushing's syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: insights into hormonal control of adrenocortical Tumorigenesis 1","volume":"83","author":"Chabre","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.beem.2018.01.003_bib25","first-page":"3531","article-title":"Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing\u2019s syndrome\u202f?*","volume":"85","author":"Mircescu","year":"2000"},{"issue":"1","key":"10.1016\/j.beem.2018.01.003_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1530\/EJE-10-0195","article-title":"Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome","volume":"163","author":"Lib\u00e9","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2018.01.003_bib27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2265.2004.02048.x","article-title":"Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study","volume":"61","author":"Reznik","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.beem.2018.01.003_bib28","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1210\/jc.2009-0516","article-title":"Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors","volume":"94","author":"Hsiao","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2018.01.003_bib29","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1750-1172-8-142","article-title":"ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in\u00a0vivo and in\u00a0vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11\u03b2-hydroxylase","volume":"8","author":"Hofland","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"10.1016\/j.beem.2018.01.003_bib30","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.peptides.2008.06.011","article-title":"Hyper-responsiveness of adrenal gland to vasopressin resulting in enhanced plasma cortisol in patients with adrenal nodule(s)","volume":"29","author":"Suzuki","year":"2008","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.beem.2018.01.003_bib31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/EJE-10-0058","article-title":"Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing's syndrome","volume":"163","author":"De Groot","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.beem.2018.01.003_bib32","first-page":"2414","article-title":"Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension","volume":"82","author":"Lacroix","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.01.003_bib33","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1365-2265.1997.3011151.x","article-title":"Adrenocorticotrophin-independent macronodular adrenal hyperplasia in a patient with lysine vasopressin responsiveness but insensitivity to gastric inhibitory polypeptide","volume":"47","author":"Iida","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.beem.2018.01.003_bib34","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2169\/internalmedicine.36.536","article-title":"Adrenocorticotropin-independent macronodular adrenocortical hyperplasia associated with multiple colon adenomas\/carcinomas which showed a point mutation in the APC gene","volume":"36","author":"Yamakita","year":"1997","journal-title":"Intern Med"},{"key":"10.1016\/j.beem.2018.01.003_bib35","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2265.1998.00490.x","article-title":"In\u00a0vivo and in\u00a0vitro effects of AVP and V 1a receptor antagonist on Cushing\u2019s syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia","author":"Daidoh","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.beem.2018.01.003_bib36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1385\/ENDO:19:3:319","article-title":"Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland","volume":"19","author":"Miyamura","year":"2002","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.beem.2018.01.003_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1530\/eje.1.02324","article-title":"Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors","volume":"156","author":"Vezzosi","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.beem.2018.01.003_bib38","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2169\/internalmedicine.52.8869","article-title":"A\u00a0marked difference in the vasopressin responsiveness between the adrenal glands in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia","volume":"52","author":"Miyata","year":"2013","journal-title":"Intern Med"},{"issue":"6","key":"10.1016\/j.beem.2018.01.003_bib39","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2265.2008.03471.x","article-title":"Familial vasopressin-sensitive ACTH-independent macronodular adrenal hyperplasia (VPs-AIMAH): clinical studies of three kindreds","volume":"70","author":"Gagliardi","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2018.01.003_bib40","series-title":"Mantero F Serono Symposia","first-page":"403","article-title":"Direct effect of lysine-vasopressin on cortisol production in isolated adrenal cells from nodular adrenocortical hyperplasia","volume":"57","author":"Itagaki","year":"1989"},{"key":"10.1016\/j.beem.2018.01.003_bib41","first-page":"2336","article-title":"Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia","volume":"80","author":"Horiba","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2018.01.003_bib42","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2265.2005.02387.x","article-title":"Ectopic expression of vasopressin V1b and V2 receptors in the adrenal glands of familial ACTH-independent macronodular adrenal hyperplasia","volume":"63","author":"Lee","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.beem.2018.01.003_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-07-0413","article-title":"Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates","volume":"196","author":"Louiset","year":"2008","journal-title":"J\u00a0Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2018.01.003_bib44","first-page":"2029","article-title":"Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors","volume":"83","author":"Arnaldi","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.01.003_bib45","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jcem-34-5-852","article-title":"Responses of plasma ACTH, GH, LH and 11-hydroxycorticosteroids to various stimuli in patients with Cushing's syndrome","volume":"34","author":"Demura","year":"1972","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.01.003_bib46","first-page":"2661","article-title":"Vasopressin-responsive adrenocortical tumor in a mild Cushing's syndrome: in\u00a0vivo and in\u00a0vitro studies","volume":"80","author":"Perraudin","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2018.01.003_bib47","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1055\/s-2004-825797","article-title":"Assessing the presence of abnormal regulation of cortisol secretion by membrane hormone receptors: in\u00a0vivo and in\u00a0vitro studies in patients with functioning and non-functioning adrenal adenoma","volume":"36","author":"Dall'Asta","year":"2004","journal-title":"Horm Metab Res"},{"issue":"5","key":"10.1016\/j.beem.2018.01.003_bib48","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1365-2265.2007.03106.x","article-title":"Aberrant adrenal sensitivity to vasopressin in adrenal tumours associated with subclinical or overt autonomous hypercortisolism: is this explained by an overexpression of vasopressin receptors?","volume":"68","author":"Joubert","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"10.1016\/j.beem.2018.01.003_bib49","first-page":"5534","article-title":"Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical cushing\u2019s syndrome","volume":"86","author":"Bourdeau","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2018.01.003_bib50","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1046\/j.1365-2265.2003.01963.x","article-title":"Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia","volume":"60","author":"Tatsuno","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"10.1016\/j.beem.2018.01.003_bib51","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1210\/jc.2002-020067","article-title":"Eutopic overexpression of vasopressin V 1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia","volume":"87","author":"Mune","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2018.01.003_bib52","doi-asserted-by":"crossref","first-page":"K13","DOI":"10.1530\/EJE-17-0263","article-title":"Adrenal Cushing's syndrome during pregnancy","volume":"177","author":"Andreescu","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.01.003_bib53","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.mce.2014.11.013","article-title":"Paracrine control of steroidogenesis by serotonin in adrenocortical neoplasms","volume":"408","author":"Lefebvre","year":"2015","journal-title":"Mol Cell Endocrinol"},{"issue":"21","key":"10.1016\/j.beem.2018.01.003_bib54","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJM199911183412104","article-title":"Leuprolide acetate therapy in luteinizing hormone\u2013dependent Cushing's syndrome","volume":"341","author":"Lacroix","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"0021\u2013972; 10","key":"10.1016\/j.beem.2018.01.003_bib55","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1210\/jc.2002-021949","article-title":"Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: an in\u00a0vivo and in\u00a0vitro study","volume":"88","author":"Mannelli","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2018.01.003_bib56","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1210\/jc.2002-021107","article-title":"Overexpression of serotonin4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing's syndrome","volume":"88","author":"Cartier","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2018.01.003_bib57","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1210\/jc.2004-1256","article-title":"In\u00a0vivo and in\u00a0vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin\/gastric inhibitory polypeptide-dependent hypercortisolism","volume":"90","author":"Bertherat","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2018.01.003_bib58","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1210\/jc.2006-0538","article-title":"Expression of serotonin7 receptor and coupling of ectopic receptors to protein kinase A and ionic currents in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome","volume":"91","author":"Louiset","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2018.01.003_bib59","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/cen.12763","article-title":"An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: a single-centre experience","volume":"82","author":"Albiger","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"10.1016\/j.beem.2018.01.003_bib60","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1590\/S0004-27302007000900007","article-title":"Cellular and molecular abnormalities of a macronodular adrenal hyperplasia causing beta-blocker-sensitive Cushing's syndrome","volume":"51","author":"Mazzuco","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.beem.2018.01.003_bib61","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1210\/jc.2002-020621","article-title":"Luteinizing hormone (LH)-Responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in\u00a0vitro","volume":"88","author":"Feelders","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2018.01.003_bib62","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1677\/ERC-08-0085","article-title":"Ectopic expression of serotonin7 receptors in an adrenocortical carcinoma co-secreting renin and cortisol Endocr Relat Cancer","volume":"15","author":"Louiset","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2018.01.003_bib63","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM199711133372004","article-title":"Propanolol therapy for B-adrenergic receptors in Cushing's syndrome","author":"Lacroix","year":"1997","journal-title":"New Engl J Med"},{"issue":"1","key":"10.1016\/j.beem.2018.01.003_bib64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/EJE-15-0642","article-title":"ARMC5 mutations in a large French-Canadian family with cortisol-secreting \u03b2-adrenergic\/vasopressin responsive bilateral macronodular adrenal hyperplasia","volume":"174","author":"Bourdeau","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.01.003_bib65","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1210\/jc.2003-030917","article-title":"Human fetal nongonadal tissues contain human chorionic gonadotropin\/luteinizing hormone receptors","volume":"89","author":"Abdallah","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2018.01.003_bib66","first-page":"456","article-title":"Leuprolide acetate therapy in LH-dependent Cushing's syndrome: in\u00a0vivo and in\u00a0vitro observations","volume":"62","author":"Bovenberg","year":"2004","journal-title":"Neth J Med"},{"issue":"4","key":"10.1016\/j.beem.2018.01.003_bib67","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12022-009-9090-2","article-title":"Case report: adrenal LH\/hCG receptor overexpression and gene amplification causing pregnancy-induced Cushing's syndrome","volume":"20","author":"Chui","year":"2009","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.beem.2018.01.003_bib68","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/09513590009167660","article-title":"Presence of a Gs alpha mutation in an adrenal tumor expressing LH\/hCG receptors and clinically associated with Cushing's syndrome","volume":"14","author":"Bugalho","year":"2000","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2018.01.003_bib69","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1677\/JOE-08-0395","article-title":"Expression Profiles of the glucose-dependent insulinotropic peptide receptor and luteinizing hormone receptor in sporadic adrenocortical tumors","volume":"200","author":"Costa","year":"2008","journal-title":"J\u00a0Endocrinol"},{"issue":"October 2016","key":"10.1016\/j.beem.2018.01.003_bib70","first-page":"57","article-title":"Functional implications of LH\/hCG receptors in pregnancy-induced Cushing syndrome","volume":"1","author":"Plockinger","year":"2017","journal-title":"J\u00a0Endocr Soc"},{"issue":"10","key":"10.1016\/j.beem.2018.01.003_bib71","first-page":"3","article-title":"Food-dependent Cushing\u2019s syndrome\u202f: possible involvement of leptin in cortisol hypersecretion","volume":"84","author":"Pralong","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.beem.2018.01.003_bib72","first-page":"4514","article-title":"Food-dependent Cushing's syndrome: characterization and functional role of gastric inhibitory polypeptide receptor in the adrenals of three patients 1","volume":"83","author":"Lebrethon","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2018.01.003_bib73","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1210\/jc.84.8.2616","article-title":"Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent Cushing's syndrome 1","volume":"84","author":"N'Diaye","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2018.01.003_bib74","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1210\/jcem.87.5.8458","article-title":"The ectopic expression of the gastric inhibitory polypeptide receptor is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors","volume":"87","author":"Groussin","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2018.01.003_bib75","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/sj.onc.1207277","article-title":"Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators","volume":"23","author":"Bourdeau","year":"2004","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.beem.2018.01.003_bib76","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-0030-1270523","article-title":"Transient efficacy of octreotide and pasireotide (SOM230) treatment in GIP-dependent Cushing's syndrome","volume":"43","author":"Preumont","year":"2011","journal-title":"Horm Metab Res"},{"issue":"2","key":"10.1016\/j.beem.2018.01.003_bib77","first-page":"583","article-title":"Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in\u00a0vivo and in\u00a0vitro studies","volume":"86","author":"Tsagarakis","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.01.003_bib78","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1210\/jc.2006-0221","article-title":"Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)-and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome","volume":"91","author":"Lampron","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.01.003_bib79","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1210\/en.2005-0921","article-title":"Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model","volume":"147","author":"Mazzuco","year":"2006","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.beem.2018.01.003_bib80","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1055\/s-0034-1384522","article-title":"Abnormal sensitivity to glucagon and related peptides in primary adrenal Cushing's syndrome","volume":"46","author":"Louiset","year":"2014","journal-title":"Horm Metab Res"},{"issue":"3","key":"10.1016\/j.beem.2018.01.003_bib81","first-page":"254","article-title":"Aberrant expression of glucagon receptors in adrenal glands of a patient with Cushing's syndrome and ACTH-independent macronodular adrenal hyperplasia","volume":"70","author":"de Miguel","year":"2010","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.beem.2018.01.003_bib82","doi-asserted-by":"crossref","first-page":"E253","DOI":"10.1210\/jc.2009-2281","article-title":"Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome","volume":"95","author":"Assie","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2018.01.003_bib83","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1210\/jc.2002-022001","article-title":"Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in\u00a0vitro and are associated with increased expression of the glucocorticoid receptor","volume":"88","author":"Bourdeau","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2018.01.003_bib84","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1210\/jc.2009-0031","article-title":"The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits","volume":"94","author":"Louiset","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"15","key":"10.1016\/j.beem.2018.01.003_bib85","doi-asserted-by":"crossref","first-page":"e87958","DOI":"10.1172\/jci.insight.87958","article-title":"PKA regulatory subunit 1A inactivating mutation induces serotonin signaling in primary pigmented nodular adrenal disease","volume":"1","author":"Bram","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.beem.2018.01.003_bib86","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1056\/NEJMoa1215245","article-title":"Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia","volume":"369","author":"Louiset","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"460","key":"10.1016\/j.beem.2018.01.003_bib87","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mce.2017.06.027","article-title":"The role of ARMC5 in human cell cultures from nodules of primary macronodular adrenocortical hyperplasia (PMAH)","volume":"15","author":"Cavalcante","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2018.01.003_bib88","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1677\/JOE-07-0037","article-title":"G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism","volume":"195","author":"Ye","year":"2007","journal-title":"J\u00a0Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2018.01.003_bib89","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1210\/jc.2008-1340","article-title":"Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma","volume":"94","author":"Lampron","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2018.01.003_bib90","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2265.2009.03551.x","article-title":"High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas","volume":"71","author":"Piaditis","year":"2009","journal-title":"Clin Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2018.01.003_bib91","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1365-2362.2011.02531.x","article-title":"High prevalence of autonomous aldosterone secretion among patients with essential hypertension","volume":"41","author":"Gouli","year":"2011","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"10.1016\/j.beem.2018.01.003_bib92","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1210\/jc.2012-3353","article-title":"Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension","volume":"98","author":"Markou","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2018.01.003_bib93","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1210\/jc.2015-1268","article-title":"Stress-induced aldosterone hyper-secretion in a substantial subset of patients with essential hypertension","volume":"100","author":"Markou","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.beem.2018.01.003_bib94","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1210\/jc.2011-0573","article-title":"Significance of adrenocorticotropin stimulation test in the diagnosis of an aldosterone-producing adenoma","volume":"96","author":"Sonoyama","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2018.01.003_bib95","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1210\/jc.2014-3551","article-title":"Diagnostic value of ACTH stimulation test in determining the subtypes of primary aldosteronism","volume":"100","author":"Jiang","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2018.01.003_bib96","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/jhh.2013.116","article-title":"A\u00a0marked proportional rise in IVC aldosterone following cosyntropin administration during AVS is a signal to the presence of adrenal hyperplasia in primary aldosteronism","volume":"28","author":"Kline","year":"2014","journal-title":"J\u00a0Hum Hypertens"},{"issue":"4","key":"10.1016\/j.beem.2018.01.003_bib97","doi-asserted-by":"crossref","first-page":"E550","DOI":"10.1210\/jc.2014-3660","article-title":"Mast cell hyperplasia is associated with aldosterone hypersecretion in a subset of aldosterone-producing adenomas","volume":"100","author":"Duparc","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2018.01.003_bib98","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1530\/eje.1.02051","article-title":"Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas","volume":"153","author":"Cartier","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.01.003_bib99","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2008.10.036","article-title":"G\u00a0protein-coupled receptor expression in the adult and fetal adrenal glands","volume":"300","author":"Xing","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2018.01.003_bib100","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1210\/jc.2005-1298","article-title":"Elevated expression of luteinizing hormone receptor in aldosterone- producing adenomas","volume":"91","author":"Saner-Amigh","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2018.01.003_bib101","first-page":"318","article-title":"LH, progesterone, and TSH can stimulate aldosterone in\u00a0vitro: a study on normal adrenal cortex and aldosterone producing adenoma","volume":"46","author":"Nicolini","year":"2014","journal-title":"Horm Metab Res"},{"issue":"3","key":"10.1016\/j.beem.2018.01.003_bib102","first-page":"320","article-title":"Aberrant gonadotropin-releasing hormone receptor (GnRHR) expression and its regulation of CYP11B2 expression and aldosterone production in adrenal aldosterone-producing adenoma (APA)","volume":"27","author":"Nakamura","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2018.01.003_bib103","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/EJE-10-0879","article-title":"A\u00a0case of primary aldosteronism in pregnancy: do LH and GNRH receptors have a potential role in regulating aldosterone secretion?","volume":"164","author":"Albiger","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"15","key":"10.1016\/j.beem.2018.01.003_bib104","first-page":"1429","article-title":"Pregnancy, Primary Aldosteronism, and Adrenal CTNNB1 Mutations","volume":"373","author":"Teo","year":"2016"},{"issue":"15","key":"10.1016\/j.beem.2018.01.003_bib105","first-page":"1493","article-title":"Pregnancy, primary aldosteronism, and somatic CTNNB1 mutations","volume":"374","author":"Berthon","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.beem.2018.01.003_bib106","first-page":"1","article-title":"Gonadotropin-Releasing hormone stimulate aldosterone production in a subset of\u00a0aldosterone-producing adenoma","volume":"95","author":"Kishimoto","year":"2016","journal-title":"Med (United States)"},{"issue":"4","key":"10.1016\/j.beem.2018.01.003_bib107","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1210\/jc.2005-1453","article-title":"Evidence for a role of vasopressin in the control of aldosterone secretion in primary aldosteronism: in\u00a0vitro and in\u00a0vivo studies","volume":"91","author":"Perraudin","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2018.01.003_bib108","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1530\/eje.0.1370262","article-title":"Absence of angiotensin II type 1 receptor gene mutations in human adrenal tumors","volume":"137","author":"Sachse","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2018.01.003_bib109","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2265.1991.tb01732.x","article-title":"Testosterone-secreting virilizing adrenal adenoma with human chorionic gonadotrophin receptors and 21-hydroxylase deficiency","volume":"4","author":"Leinonen","year":"1991","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2018.01.003_bib110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1210\/jc.2002-021292","article-title":"Virilization in bilateral macronodular adrenal hyperplasia controlled by luteinizing hormone","volume":"88","author":"Goodarzi","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2018.01.003_bib111","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2265.2005.02411.x","article-title":"Expression of ACTH receptor pathway genes in glucose-dependent insulinotrophic peptide (GIP)-dependent Cushing's syndrome","volume":"64","author":"Antonini","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2018.01.003_bib112","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1677\/jme.1.01765","article-title":"The Sp transcription factors are involved in the cellular expression of the human glucose-dependent insulinotropic polypeptide receptor gene and overexpressed in adrenals of patients with Cushing's syndrome","volume":"35","author":"Baldacchino","year":"2005","journal-title":"J\u00a0Mol Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2018.01.003_bib113","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3904\/kjim.2014.29.5.667","article-title":"Adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with abnormal cortisol secretion mediated by catecholamines","volume":"29","author":"Rhee","year":"2014","journal-title":"Korean J Intern Med"},{"issue":"3","key":"10.1016\/j.beem.2018.01.003_bib114","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1507\/endocrj.50.333","article-title":"A\u00a0case of ACTH-independent macronodular adrenal hyperplasia: simultaneous expression of several aberrant hormone receptors in the adrenal gland","volume":"50","author":"Miyamura","year":"2003","journal-title":"Endocr J"},{"issue":"3","key":"10.1016\/j.beem.2018.01.003_bib115","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s12020-009-9246-3","article-title":"Improvement of hypercortisolism by \u03b2-blocker therapy in subclinical Cushing's syndrome associated with ACTH-independent macronodular adrenocortical hyperplasia","volume":"36","author":"Oki","year":"2009","journal-title":"Endocrine"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18300034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X18300034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:53:51Z","timestamp":1761497631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X18300034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":115,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1521690X18300034"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2018.01.003","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant G-protein coupled hormone receptor in adrenal diseases","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}